Novel drug holds promise for treating Duchenne muscular dystrophy

A novel drug holds promise for treating Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes severe muscle degeneration.

Revolution Medicines breaks ground in challenging pancreatic cancer with two RAS drugs

In an interview Friday, Revolution Medicines CEO Mark Goldsmith, who says he prefers to understate rather than exaggerate, floated a lofty goal: cure pancreatic cancer

October 26, 2024

Pharma’s big patent cliff, more obesity fundraising, and a failed ALS study

Why could we see more deal-making at this year’s J. P. Morgan Healthcare conference? Why are investors concerned about a slowdown in U.S. biotech innovation?

January 9, 2025

Open-Source Healthcare Data Platform: Tuva Health and MultiCare Join Forces

What You Should Know: – Tuva Health, the world’s first open-source healthcare data transformation platform, today announced it has partnered with MultiCare Connected Care (MCC), MultiCare Health System’s

February 13, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.